| 3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one | IC50 | 106.0 [1] |
| Olaparib | IC50 | 3.0 [1] |
| Veliparib | IC50 | 17.5 [1], 70.0 [2], 137.0 [3] |
| Veliparib | Ki | 5.0 [1] |
| IWR-1-endo | IC50 | 18700.0 [1], 25000.0 [2], 35000.0 [3], 170000.0 [4] |
| N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide | IC50 | 33.5 [1], 382.0 [2] |
| Rucaparib | IC50 | 28.2 [1], 138.0 [2] |
| Niraparib | IC50 | 2.1 [1], 15.3 [2] |
| Nvp-tnks656 | IC50 | 19000.0 [1], 32000.0 [2] |
| 4,4'-Oxydibenzamide | IC50 | 100000.0 [1] |
| 2-(Azetidin-3-yl)-1H-benzimidazole-4-carboxamide | Ki | 11.0 [1] |
| 2-[4-(4-Fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]-N-(thiophen-2-ylmethyl)acetamide | IC50 | 19000.0 [1] |
| 2-[4-(4-Fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]-N-propylacetamide | IC50 | 19000.0 [1] |
| N-[(4-Oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]-3-phenyl-N-(thiophen-2-ylmethyl)propanamide | IC50 | 19000.0 [1], 56400.0 [2] |
| 3-(3-Hydroxyphenyl)-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]-N-(thiophen-2-ylmethyl)propanamide | IC50 | 19000.0 [1] |
| N-[(4-Oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]-3-phenyl-N-(thiophen-3-ylmethyl)propanamide | IC50 | 10400.0 [1] |
| 2-[4-(4-Fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]acetamide | IC50 | 3100.0 [1], 3150.0 [2] |
| 2-[4-(4-Fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]-N-(pyridin-2-ylmethyl)acetamide | IC50 | 19000.0 [1] |
| 2-[4-(4-Fluorobenzoyl)piperidin-1-yl]-N-(2-methylpropyl)-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]acetamide | IC50 | 19000.0 [1] |
| N-Benzyl-2-[4-(4-fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]acetamide | IC50 | 19000.0 [1] |
| Talazoparib | Ki | 0.85 [1] |
| Bmn-673 8R,9S | IC50 | 4.1 [1] |
| 4-Methoxybenzamide | IC50 | 77000.0 [1] |
| 2-(4-Nitrophenyl)quinazolin-4-ol | IC50 | 2064.0 [1] |
| 2-(4-Chlorophenyl)quinazolin-4-ol | IC50 | 2600.0 [1] |
| 2-(4-Bromophenyl)-3,4-Dihydroquinazolin-4-One | IC50 | 100000.0 [1] |
| 3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid | IC50 | 125.0 [1] |
| 2-(4-Fluorophenyl)quinazolin-4-ol | IC50 | 4688.0 [1] |
| 2-(4-Methylphenyl)-4H-chromen-4-one | IC50 | 27800.0 [1] |
| 1H-Benzimidazole-7-carboxamide, 2-(1-propyl-4-piperidinyl)- | Ki | 5.0 [1] |
| 5-[[4-(4-Methoxyphenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-3-(4-methylphenyl)-1,2,4-oxadiazole | IC50 | 19000.0 [1] |
| 2-[2-Fluoro-4-[(2S)-2-pyrrolidinyl]phenyl]-1H-benzimidazole-7-carboxamide | Ki | 1.5 [1] |
| 4-[[3-[(6S)-3-(1,1-Difluoroethyl)-6-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine-7-carbonyl]phenyl]-difluoromethyl]-2H-phthalazin-1-one | IC50 | 30.0 [1] |
| 8-Chloro-2-{3-[4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl]propyl}-3,4-dihydroquinazolin-4-one | IC50 | 500.0 [1] |
| CID 16665853 | Ki | 3.0 [1] |
| 5-(2-Oxo-2-phenylethoxy)isoquinolin-1(2H)-one | IC50 | 1000.0 [1] |
| 1H-Benzimidazole-7-carboxamide, 2-[4-(2-pyridinyl)phenyl]- | Ki | 2.0 [1] |
| 2-(4-Nitrophenyl)-4H-chromen-4-one | IC50 | 8300.0 [1] |
| 4-Quinazolinol, 5,6,7,8-tetrahydro-2-(4-methyl-1-piperazinyl)- | IC50 | 3600.0 [1] |
| 8-Methoxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one | IC50 | 928.0 [1] |
| 8-Methoxy-2-phenyl-quinazolin-4-ol | IC50 | 1539.0 [1] |
| 8-Methyl-2-[4-(Trifluoromethyl)phenyl]-3h-Quinazolin-4-One | IC50 | 3098.0 [1] |
| 8-Methoxy-2-[4-(Trifluoromethyl)phenyl]-3,4-Dihydroquinazolin-4-One | IC50 | 570.0 [1] |
| Morpholin-4-Yl[4-(Tetrazolo[1,5-A]quinoxalin-4-Ylamino)phenyl]methanone | IC50 | 5011.87 [1] |
| 3-(4-Cyanophenyl)quinoxaline-5-carboxamide | IC50 | 8.0 [1] |
| 4'-Isopropylflavone | IC50 | 34900.0 [1] |
| 2-(4-Pyridine-3-ylphenyl)-1H-benzimidazole-4-carboxamide | Ki | 8.0 [1] |
| 2-(4-Tert-Butylphenyl)-2,3-dihydroquinazoline-4(1H)-one | IC50 | 100000.0 [1] |
| 4-[(3Ar,4r,7s,7as)-1,3-Dioxooctahydro-2h-4,7-Methanoisoindol-2-Yl]-N-(Quinolin-8-Yl)benzamide | IC50 | 100000.0 [1] |
| 3H-Pyridazino(3,4,5-de)quinazolin-3-one, 8-((1,3-dihydro-2H-isoindol-2-yl)methyl)-1,2-dihydro- | IC50 | 1.0 [1] |
| N-(2-Methoxyphenyl)-4-{[3-(4-Oxo-3,4-Dihydroquinazolin-2-Yl)propanoyl]amino}benzamide | IC50 | 931.0 [1] |
| 2-[4-(Trifluoromethyl)phenyl]-3h-Quinazolin-4-One | IC50 | 10000.0 [1] |
| 2-[4-[6-[(3R,5S)-3,5-Dimethylpiperazin-1-yl]-4-methylpyridin-3-yl]phenyl]-7-methyl-3H-pyrrolo[2,3-d]pyrimidin-4-one | IC50 | 990.0 [1] |
| 2-(4-Chlorophenyl)-8-methyl-3H-quinazolin-4-one | IC50 | 6350.0 [1] |
| 2-(4-Fluorophenyl)-8-methyl-3H-quinazolin-4-one | IC50 | 683.0 [1] |
| Benzyl N-[[4-(8-methyl-4-oxo-3H-quinazolin-2-yl)phenyl]methyl]carbamate | IC50 | 100000.0 [1] |
| 2-(4-Bromophenyl)-8-methyl-3H-quinazolin-4-one | IC50 | 10529.0 [1] |
| 2-(4-Chlorophenyl)-8-methoxy-3H-quinazolin-4-one | IC50 | 6022.0 [1] |
| 2-[4-(Trifluoromethyl)phenyl]-3,5,6,8-tetrahydrothiopyrano[3,4-d]pyrimidin-4-one | IC50 | 479.0 [1] |
| 3-(4-Methoxyphenyl)-5-[[4-(4-methoxyphenyl)-5-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole | IC50 | 19000.0 [1] |
| 3-(3,4-Dimethoxyphenyl)-5-[[4-(4-methoxyphenyl)-5-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole | IC50 | 19000.0 [1] |
| 4-Tert-Butyl-N-(5,6-Dihydro[1,3]thiazolo[2,3-C][1,2,4]triazol-3-Yl)benzamide | IC50 | 19000.0 [1] |
| 4-(4-Carbamoylphenoxy)benzoic acid | IC50 | 100000.0 [1] |
| 2-(4-(Pyridin-4-yl)phenyl)-1H-benzimidazole-4-carboxamide | Ki | 1.0 [1] |
| 4-[(2-Fluorophenyl)methoxy]benzamide | IC50 | 100000.0 [1] |
| 2-[4-[3-[(4-Oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]pyridine-3-carbonitrile | IC50 | 1.0 [1] |
| N-{4-[(2-Chlorophenyl)(Pyrimidin-4-Yl)carbamoyl]phenyl}-4-Methoxybenzamide | IC50 | 100000.0 [1] |
| 2-[(2s)-2-Methylpyrrolidin-2-Yl]-1h-Benzimidazole-7-Carboxamide | Ki | 2.0 [1] |
| 2-(3-Methylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide | Ki | 2.0 [1] |
| 6-Fluoro-2-[(2R)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide | Ki | 4.0 [1] |
| 1-[3-[4-(2-Chlorophenyl)-5-pyrimidin-4-yl-1,2,4-triazol-3-yl]cyclobutyl]-2-oxo-3H-benzimidazole-5-carbonitrile | IC50 | 100000.0 [1] |
| Tert-butyl (3S)-3-[[5-[(2,4-dioxoquinazolin-1-yl)methyl]-2-fluoropyridin-3-yl]carbamoyl]pyrrolidine-1-carboxylate | IC50 | 8.6 [1] |
| Parp-2-IN-1 | IC50 | 11.5 [1] |
| (3S)-N-[5-[(2,4-Dioxoquinazolin-1-yl)methyl]-2-fluoropyridin-3-yl]-1-phenylpyrrolidine-3-carboxamide | IC50 | 4.1 [1] |
| (E)-3-[4-[[4-[2-Fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]methyl]phenyl]-N-hydroxyprop-2-enamide | IC50 | 2.53 [1] |
| 4-[[4-[2-Fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]methyl]-N-hydroxybenzamide | IC50 | 31.52 [1] |
| 6-Fluoro-2-(4,5,6,7-tetrahydrofuro[2,3-c]pyridin-2-yl)-1H-benzimidazole-4-carboxamide | IC50 | 144.0 [1] |
| 2-(4-Fluorophenyl)-8-methoxyquinazolin-4(3H)-one | IC50 | 1562.0 [1] |
| Pamiparib | IC50 | 0.5 [1] |
| 3-[(4-Oxo-3H-quinazolin-2-yl)sulfanyl]-N-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)cyclohexyl]propanamide | IC50 | 2450.0 [1] |
| N-[trans-4-(4-Cyanophenoxy)cyclohexyl]-3-[(4-Oxo-3,4-Dihydroquinazolin-2-Yl)sulfanyl]propanamide | IC50 | 1760.0 [1] |
| Benzyl N-{[4-(4-Oxo-3,4-Dihydroquinazolin-2-Yl)phenyl]methyl}carbamate | IC50 | 10000.0 [1] |
| 2-(4-((Pyridin-4-Yl)methyl)piperazin-1-Yl)-3,4,5,6,7,8-Hexahydroquinazolin-4-One | IC50 | 4200.0 [1] |
| 4-[3-(4-Oxo-3H-quinazolin-2-yl)propanoylamino]-N-quinolin-8-ylbenzamide | IC50 | 6900.0 [1] |
| 4-[3-(8-Methyl-4-oxo-3H-quinazolin-2-yl)propanoylamino]-N-quinolin-8-ylbenzamide | IC50 | 11600.0 [1] |
| 2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-3H-thiopyrano[3,2-D]pyrimidin-4(6H)-one | IC50 | 4080.0 [1] |
| N-(Cyclopropylmethyl)-2-[4-(4-fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]acetamide | IC50 | 19000.0 [1] |
| N-Ethyl-2-[4-(4-fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydropyrano[4,3-d]pyrimidin-2-yl)methyl]acetamide | IC50 | 19000.0 [1] |
| 3-(8-Methyl-4-oxo-3H-quinazolin-2-yl)propanoic acid | IC50 | 145.0 [1] |
| 2-(4-Bromophenyl)-8-methoxy-3H-quinazolin-4-one | IC50 | 259.0 [1] |
| 6-Fluoro-2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)-1H-benzimidazole-4-carboxamide | IC50 | 73.0 [1] |
| 6-Fluoro-2-(4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-1H-benzimidazole-4-carboxamide | IC50 | 124.0 [1] |
| (3S)-1-(2-Cyclopropylethyl)-N-[5-[(2,4-dioxoquinazolin-1-yl)methyl]-2-fluoropyridin-3-yl]pyrrolidine-3-carboxamide | IC50 | 1.0 [1] |
| Tert-butyl (3S)-3-[[2-chloro-5-[(2,4-dioxoquinazolin-1-yl)methyl]pyridin-3-yl]carbamoyl]pyrrolidine-1-carboxylate | IC50 | 12.2 [1] |
| Tert-butyl (3S)-3-[[5-[(2,4-dioxoquinazolin-1-yl)methyl]pyridin-3-yl]carbamoyl]pyrrolidine-1-carboxylate | IC50 | 100.0 [1] |
| (3S)-1-(Cyclopropylmethyl)-N-[5-[(2,4-dioxoquinazolin-1-yl)methyl]-2-fluoropyridin-3-yl]pyrrolidine-3-carboxamide | IC50 | 3.6 [1] |
| (3S)-N-[2-Chloro-5-[(2,4-dioxoquinazolin-1-yl)methyl]phenyl]pyrrolidine-3-carboxamide;2,2,2-trifluoroacetic acid | IC50 | 100.0 [1] |
| 2-[4-(Trifluoromethyl)phenyl]-7,8-dihydro-3H-thiopyrano[4,3-d]pyrimidine-4,5-dione | IC50 | 141.0 [1] |
| 2-[3-(Propylamino)pyrrolidine-1-carbonyl]-1H-benzimidazole-4-carboxamide | IC50 | 75.0 [1] |
| (3S)-1-(Cyclopropanecarbonyl)-N-[5-[(2,4-dioxoquinazolin-1-yl)methyl]-2-fluoropyridin-3-yl]pyrrolidine-3-carboxamide | IC50 | 4.5 [1] |